Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients [Phase 2]
Phase 2 trial evaluating safety and tolerability of repeated subcutaneous injections of CAD106 in Alzheimer's disease patients has been comp…
-
CLINICAL_TRIALS trial_result · 2020-12-16Clinical Trial Update: Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) [NA]
Altoida conducted a clinical trial to evaluate its computerized NMI marker as a potential marker for functional impairment in Alzheimer's di…
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease [Phase 2]
Phase 2 clinical trial update for [18F]THK-5351 PET imaging across Alzheimer's disease, mild cognitive impairment, and other neurodegenerati…
-
FDA approval · 2020-12-11FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (POLYGEN PHARMACEUTICALS INC.)
The FDA approved an original ANDA for memantine hydrochloride by PolyGen Pharmaceuticals, enabling a generic version of memantine for Alzhei…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Aggression Prevention Training for Caregivers of Persons With Dementia (APT) [NA]
Clinical trial completed evaluating aggression prevention training for caregivers of persons with dementia; results posted in 2020.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Play Intervention for Dementia for Promoting Cognitive Function: A Feasibility Study [NA]
Feasibility study evaluating a play intervention to promote cognitive function in individuals with dementia, including Alzheimer's disease; …
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study
A completed clinical trial assessing cerebral haemodynamic changes during cognitive testing using fTCD, involving Mild Cognitive Impairment,…
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial comparing PF-04447943 to placebo in mild to moderate Alzheimer's disease has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease [Phase 1]
Phase 1 trial evaluating safety, tolerability, and blood levels of multiple doses of PF-044467943 (with donepezil) in mild to moderate Alzhe…
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update evaluating rosiglitazone for efficacy and safety in Alzheimer's disease has completed with results posted.
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited, updating an existing approved produ…
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited, indicating approval of a change…
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Z-Drugs for Sleep Disorders in Alzheimer's Disease [Phase 3]
Phase 3 trial update on Z-Drugs for sleep disorders in Alzheimer's disease completed.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. [Phase 2]
Phase 2 trial update for BI 425809 in cognitive impairment due to Alzheimer’s disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 randomized study completed evaluating the safety of GRF6019 infusions in mild to moderate Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: Multimodal Biomarkers for Diagnosis and Prognosis in VCI [Phase 3]
Phase 3 clinical trial evaluating multimodal biomarkers for diagnosis and prognosis in vascular cognitive impairment and Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Development of An Exergame for Caregivers of Individuals With Alzheimer's Disease or Related Dementias [NA]
Clinical trial update on an exergame developed for caregivers of individuals with Alzheimer's disease or related dementias; study status is …
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Rasagiline Rescue in Alzheimer's Disease Clinical Trial [Phase 2]
Phase 2 clinical trial investigating rasagiline as a rescue therapy in Alzheimer's disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine [Phase 2]
Phase 2 trial update for bryostatin in moderately to severely Alzheimer’s disease patients not on memantine has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects [EARLY_Phase 1]
Phase 1 exploratory study of flortaucipir injection in healthy volunteers and cognitively impaired subjects with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease [Phase 1]
Phase 1 clinical trial update for flortaucipir PET imaging in preclinical, prodromal, and dementia stages of Alzheimer’s disease; results po…
-
FDA approval · 2020-09-21FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for a generic donepezil hydrochloride product manufactured by Solco Healthcare US, LLC.
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Tricaprilin in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for tricaprilin in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease [Phase 2]
Phase 2 clinical trial exploring curcumin and yoga therapy for individuals at risk of Alzheimer's disease with mild cognitive impairment.